| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 103974-36-3 | 2,5-Cyclohexadien-1-ol,1-methyl-4-(1-methylethyl)-, cis-; 2,5-Cyclohexadien-1-ol,1-methyl-4-(1-methylethyl)-,cis-(9CI) |  | C10H16O | 詳情 | 供應商 | |
| 103974-35-2 | 2,5-Cyclohexadien-1-ol,1-methyl-4-(1-methylethyl)-, trans-; 2,5-Cyclohexadien-1-ol,1-methyl-4-(1-methylethyl)-,trans-(9CI) |  | C10H16O | 詳情 | 供應商 | |
| 103906-12-3 | 2-Naphthalenecarboxylicacid, 5-amino-6-hydroxy-; 2-Naphthoicacid, 5-amino-6-hydroxy- (6CI) |  | C11H9NO3 | 詳情 | 供應商 | |
| 103901-87-7 | 2H-Benzimidazol-2-one,1,3-dihydro-1,4,7-trimethyl-; 2H-Benzimidazol-2-one,1,3-dihydro-1,4,7-trimethyl-(9CI) |  | C10H12N2O | 詳情 | 供應商 | |
| 103897-99-0 | 2-Azetidinecarboxylicacid, 1-acetyl-, methyl ester; 2-Azetidinecarboxylicacid, 1-acetyl-, methyl ester, (?à)- |  | C7H11NO3 | 詳情 | 供應商 | |
| 103882-85-5 | 2(1H)-Pyrimidinone,4-amino-1-(2-deoxy-2,2-difluoro-D-threo-pentofuranosyl)-; 3Epigemcitabine; 4-Amino-1-(Deoxy-2,2-difluoro-D-threo-pentofuranosyl)-2(1H)-pyrimidinon; (Gemcitabine Impurity; 3’-Epi Gemcitabine (Gemcitabine Impurity); 4-Amino-1-(Deoxy-2,2-difluoro-D-threo-pentofuranosyl)-2(1H)-pyrimidinone |  | C9H11F2N3O4 | 詳情 | 供應商 | |
| 17809-07-3 | 2-Naphthalenecarboxamide,4-[2-(2,4-dinitrophenyl)diazenyl]-N-(2-ethoxyphenyl)-3-hydroxy-; 2-Naphthalenecarboxamide,4-[(2,4-dinitrophenyl)azo]-N-(2-ethoxyphenyl)-3-hydroxy- (9CI); 2-Naphtho-o-phenetidide, 4-[(2,4-dinitrophenyl)azo]-3-hydroxy- (6CI,8CI) |  | C25H19N5O7 | 詳情 | 供應商 | |
| 103849-16-7 | 2H-1-Benzopyran-2-one,3,4-dihydro-8-hydroxy-4-phenyl-; 8-Hydroxy-3,4-dihydro-4-phenylcoumarin |  | C15H12O3 | 詳情 | 供應商 | |
| 15649-41-9 | 2-Butenedioicacid, 2,3-dichloro-, diethyl ester, (Z)- (9CI); Maleicacid, dichloro-, diethyl ester (8CI); (Z)-2,3-Dichloro-2-butenedioic aciddiethyl ester; Dichloromaleic acid diethyl ester; Diethyl dichloromaleate |  | C8H10Cl2O4 | 詳情 | 供應商 | |
| 99577-57-8 | 2,13-Octadecadienal,(2E,13Z)- |  | C18H32O | 詳情 | 供應商 | |
| 36716-01-5 | 2-Propen-1-one,3-(1,3-benzodioxol-5-yl)-1-(4-bromophenyl)-; NSC83477 |  | C16H11BrO3 | 詳情 | 供應商 | |
| 132873-34-8 | 2-Naphthalenamine,1,2,3,4-tetrahydro-8-(methylthio)-N,N-dipropyl-, hydrochloride, (2R)- (9CI); 2-Naphthalenamine,1,2,3,4-tetrahydro-8-(methylthio)-N,N-dipropyl-, hydrochloride, (R)-; LY 274601 |  | C17H28ClNS | 詳情 | 供應商 | |
| 103852-00-2 | 2-Furancarboxylic acid,5-[(dimethylamino)methyl]-, hydrazide |  | C8H13N3O2 | 詳情 | 供應商 | |
| 17338-11-3 | 2-Thiazolidinimine,3-phenyl-, hydrobromide (1:1); 2-Thiazolidinimine,3-phenyl-, monohydrobromide (9CI); 2-Thiazolinium, 2-amino-3-phenyl-, bromide(8CI) |  | C9H10N2S.BrH | 詳情 | 供應商 | |
| 26309-94-4 | 2H-1,4-Benzodiazepin-2-one,1-(2-butoxyethyl)-7-chloro-1,3-dihydro-5-phenyl- |  | C21H23ClN2O2 | 詳情 | 供應商 | |
| 7467-54-1 | 2-Butanol,1-[(6-quinolinylmethyl)amino]-; 2-Butanol,1-[(6-quinolylmethyl)amino]- (8CI); NSC 400970 |  | C14H18N2O | 詳情 | 供應商 | |
| 7038-64-4 | 2-Pyrimidinamine,4,5,6-trichloro-N,N-diethyl-; Pyrimidine,4,5,6-trichloro-2-(diethylamino)- (7CI,8CI) |  | C8H10Cl3N3 | 詳情 | 供應商 | |
| 4480-69-7 | 25,26-Dinoroleanane,9,13-dimethyl-, (8a,9b,10a,13a,14b)- (9CI); D:B-Friedooleanane(8CI); Alnusane; Glutane; Picene,docosahydro-2,2,4a,6a,9,9,12b,14a-octamethyl-, (4aR,6aR,6bS,8aR,12aR,12bS,14aS,14bR)-; [4aR-(4aa,6aa,6bb,8ab,12ab,12ba,14ab,14ba)]-Docosahydro-2,2,4a,6a,9,9,12b,14a-octamethylpicene |  | C30H52 | 詳情 | 供應商 | |
| 154413-61-3 | 2-Propenoic acid,3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-, (2E)-; 2-Propenoicacid, 3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-,(E)-; (E)-3-[6-[[(2,6-Dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoicacid; SB 209247; Ticolubant |  | C23H19Cl2NO3S | 詳情 | 供應商 | |
| 26943-74-8 | 2-Butanol, 3-methyl-,2-methanesulfonate; 2-Butanol,3-methyl-, methanesulfonate (8CI,9CI); 3-Methyl-2-butyl methanesulfonate |  | C6H14O3S | 詳情 | 供應商 | |